Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 May 4;187(9):1537-42.
doi: 10.1084/jem.187.9.1537.

Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice

Affiliations

Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice

T Akimoto et al. J Exp Med. .

Abstract

Signal transducers and activators of transcription 6 (STAT6) is essential for interleukin 4-mediated responses, including class switching to IgE and induction of type 2 T helper cells. To investigate the role of STAT6 in allergic asthma in vivo, we developed a murine model of allergen-induced airway inflammation. Repeated exposure of actively immunized C57BL/6 mice to ovalbumin (OVA) aerosol increased the level of serum IgE, the number of eosinophils in bronchoalveolar lavage (BAL) fluid, and airway reactivity. Histological analysis revealed peribronchial inflammation with pulmonary eosinophilia in OVA-treated mice. In STAT6-deficient (STAT6-/-) C57BL/6 mice treated in the same fashion, there were no eosinophilia in BAL and significantly less peribronchial inflammation than in wild-type mice. Moreover STAT6-/- mice had much less airway reactivity than wild-type mice. These findings suggest that STAT6 plays a crucial role in the pathogenesis of allergen-induced airway inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in serum concentrations of IgE and IgM induced by OVA treatment. The columns represent the concentration of serum IgE (a) and IgM (b) in wild-type and STAT6−/− mice after treatment with (OVA) or without (Control) OVA. Results shown are from a single experiment representative of three separate experiments. N.D., not detectable (<10 ng/ml).
Figure 2
Figure 2
Effect of STAT6 deficiency on total BAL cell number and cellular distribution of BAL fluid. BAL fluid was obtained from wild-type and STAT6−/− mice after treatment with (OVA) or without (Control) OVA. The columns represent the absolute numbers of total BAL cells, eosinophils, neutrophils, macrophages, and other cells (mostly lymphocytes) per animal. Results shown are from a single experiment representative of three separate experiments.
Figure 3
Figure 3
Microscopic examination of lung tissues from wild-type and STAT6−/− mice. Lung preparations from both wild-type and STAT6−/− mice treated with or without OVA were stained with hematoxylin-eosin. Photomicrographs of these preparations were evaluated infiltration of eosinophils and other lymphocytes in bronchial mucosa and perivascular sheaths in lung. Noticeable cell accumulation of eosinophils appeared in lungs from OVA-treated wild-type mice (A). In contrast, the inflammatory cells were not shown in lungs from OVA-treated STAT6−/− mice (B). The lungs taken from untreated wild-type mice represent normal lung histology (C). Original magnification: 200.
Figure 4
Figure 4
Effect of STAT6 deficiency on airway reactivity in OVA-treated mice. Airway reactivity assessed by measurement of RL after intravenous Ach challenge in wild-type mice (circles) and STAT6−/− mice (squares) treated with (closed symbols) or without (open symbols) OVA. Only in wild-type mice, OVA treatment significantly increased airway reactivity compared with that in the untreated group (*P <0.05). Results shown are from a single experiment representative of three separate experiments.

References

    1. Burrow B, Martines F, Halonen M, Barbee R, Cline M. Association of asthma with serum IgE levels and skin test reactivity to allergens. N Engl J Med. 1989;320:271–277. - PubMed
    1. Sears MR, Burrows B, Flannery EM, Herbinson GP, Hewitt CJ, Holdaway MD. Relationship between airway hyperresponsiveness and serum IgE in child with asthma and in apparently normal children. N Engl J Med. 1991;325:1067–1071. - PubMed
    1. Bousquet J, Chanez P, Lacote JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Lafontaine JS, Godard P, Michel FB. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033–1039. - PubMed
    1. Djukanovic R, Roche WR, Wilson JM, Beasley CRW, Twentyman OP, Howarth PH, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990;141:263–275. - PubMed
    1. Gleich G. The eosinophil and bronchial asthma. Current understanding. J Allergy Clin Immunol. 1990;85:422–436. - PubMed

Publication types